Ozato K, Ebert J D
J Exp Med. 1976 Jan 1;143(1):1-14. doi: 10.1084/jem.143.1.1.
In an attempt to modulate the recognition processes that occur on lymphocyte membranes in mixed lymphocyte culture, responding cortisone resistant thymocytes or stimulating spleen cells (treated with mitomycin C) were pretreated with native concanavalin A (N-Con A) or succinyl-Con A (S-Con A). Highly significant cell proliferation was observed in syngeneic combinations when either the responding cells or the stimulating cells were so treated with Con A, although Con A pretreatment alone was never mitogenic. In allogeneic combinations the proliferative response with Con A pretreatment of either partner on day 3 was five to seven times higher than in the normal mixed lymphocyte reactions. The triggering of proliferation was dependent on two factors: (a) The presence of spleen cells as the stimulating cells (thymocytes were much less effective). (b) The binding of Con A molecules to either one of the partners, the effect being abrogated by the specific inhibitor of Con A, alpha-mannopyranoside. The optimal concentration of S-Con A was about twice that of N-Con A. Even more striking was the observation that cultures in which either one of the partners was pretreated with Con A in allogeneic combinations showed a strong suppression (60-80% inhibition) in the subsequent generation of the cytotoxic lymphocytes (CL). The Con A concentration required to trigger a proliferative response corresponded to that for suppressing the generation of CL. Con A pretreatment did not result in a cytotoxic activity toward syngeneic tumor cells.
为了调节混合淋巴细胞培养中淋巴细胞膜上发生的识别过程,用天然刀豆球蛋白A(N-Con A)或琥珀酰刀豆球蛋白A(S-Con A)对反应性耐可的松胸腺细胞或刺激脾细胞(用丝裂霉素C处理)进行预处理。当反应细胞或刺激细胞用刀豆球蛋白A这样处理时,在同基因组合中观察到高度显著的细胞增殖,尽管单独的刀豆球蛋白A预处理从未具有促有丝分裂作用。在异基因组合中,第三天对任一伙伴进行刀豆球蛋白A预处理的增殖反应比正常混合淋巴细胞反应高五到七倍。增殖的触发取决于两个因素:(a)作为刺激细胞的脾细胞的存在(胸腺细胞的效果要差得多)。(b)刀豆球蛋白A分子与任一伙伴的结合,该作用被刀豆球蛋白A的特异性抑制剂α-甘露吡喃糖苷消除。S-Con A的最佳浓度约为N-Con A的两倍。更引人注目的是观察到,在异基因组合中,任一伙伴用刀豆球蛋白A预处理的培养物在随后的细胞毒性淋巴细胞(CL)产生中表现出强烈的抑制作用(60-80%抑制)。触发增殖反应所需的刀豆球蛋白A浓度与抑制CL产生的浓度相对应。刀豆球蛋白A预处理不会对同基因肿瘤细胞产生细胞毒性活性。